From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest Views & News

Johnson Matthey is 204 years old and out of the FTSE 100…but far from boring

By Chris Bailey | Monday 7 February 2022

Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Back in December I observed that Johnson Matthey (JMAT) had fallen out of the FTSE 100 and “it might not be one of my top two tips for next year, but it probably makes the top five and that most certainly makes it a BUY”. Part of the rationale for doubling my shareholding in the 204 year old ‘multinational speciality chemicals and sustainable technologies company’ is that I bought during the early COVID-19 fear days at a share price of below 2000p. That worked well until – as mentioned late last year – there was a bit of share price volatility, ultimately taking the shares from above 30 quid a year ago to about an 18 quid share price now. I still think though there are many reasons for holding this share in 2022, and that brings us to today’s 31 page ‘Clean Air: delivering sustainable cashflow’ presentation by the company…

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was



How is Wickes getting along?

Friday »


Tern – Is There More Bad News On The Way?

Thursday »


Zytronic – now a recovery Buy?



Buy Yourgene - target 0.6p



Keep avoiding Deliveroo shares

Friday »


Tharisa – Q1 report, still a value Buy



Sainsbury’s has a good Christmas